Transfusion-associated circulatory overload

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Transfusion-associated circulatory overload | |
|---|---|
| File:Leg Edema 01.jpg | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Dyspnea, hypertension, tachycardia, pulmonary edema, jugular venous distension |
| Complications | Heart failure, pulmonary edema |
| Onset | Within 6 hours of blood transfusion |
| Duration | Variable, depending on treatment |
| Types | N/A |
| Causes | Rapid or excessive blood transfusion |
| Risks | Pre-existing cardiac disease, renal impairment, elderly patients, infants |
| Diagnosis | Clinical evaluation, chest X-ray, echocardiogram |
| Differential diagnosis | Transfusion-related acute lung injury, allergic reaction, anaphylaxis |
| Prevention | Slow transfusion rate, use of diuretics, careful monitoring |
| Treatment | Diuretics, oxygen therapy, ventilatory support |
| Medication | N/A |
| Prognosis | Generally good with prompt treatment |
| Frequency | 1-8% of transfusions |
| Deaths | N/A |
Medical condition related to blood transfusion

Transfusion-associated circulatory overload (TACO) is a serious complication that can occur following a blood transfusion. It is characterized by an excess of fluid in the circulatory system, leading to symptoms of heart failure and pulmonary edema. TACO is a significant cause of transfusion-related morbidity and mortality, particularly in vulnerable populations such as the elderly and those with pre-existing cardiac conditions.
Pathophysiology[edit]
TACO occurs when the volume of transfused blood products exceeds the recipient's cardiovascular capacity to handle the additional fluid load. This can result in increased venous pressure, leading to fluid accumulation in the lungs and peripheral tissues. The condition is often exacerbated by rapid transfusion rates and large transfusion volumes.
Clinical Presentation[edit]
Patients with TACO typically present with symptoms of acute dyspnea, tachycardia, hypertension, and hypoxemia. Physical examination may reveal signs of jugular venous distension, rales on lung auscultation, and peripheral edema.
Diagnosis[edit]
The diagnosis of TACO is primarily clinical, based on the temporal relationship between blood transfusion and the onset of symptoms. Diagnostic criteria include:
- Acute respiratory distress within 6 hours of transfusion
- Evidence of fluid overload
- Elevated brain natriuretic peptide (BNP) levels
- Radiographic evidence of pulmonary edema
Management[edit]
The management of TACO involves supportive care and measures to reduce fluid overload. Key interventions include:
- Stopping the transfusion immediately
- Administering diuretics to promote fluid excretion
- Providing supplemental oxygen therapy
- In severe cases, mechanical ventilation may be required
Prevention[edit]
Preventive strategies for TACO focus on careful assessment of the patient's fluid status and transfusion needs. Recommendations include:
- Using the smallest effective volume of blood products
- Slowing the rate of transfusion
- Monitoring patients closely during and after transfusion, especially those at high risk
Epidemiology[edit]
TACO is one of the most common causes of transfusion-related adverse events. It is more prevalent in older adults, patients with chronic kidney disease, and those with underlying cardiac dysfunction. The incidence of TACO varies, but it is estimated to occur in 1-8% of transfusions.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian